The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mind Medicine Inc (NASDAQ: MNMD) closed the day trading at $6.36 down -0.93% from the previous closing price of $6.42. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 0.82 million shares were traded. MNMD stock price reached its highest trading level at $6.555 during the session, while it also had its lowest trading level at $6.33.
Ratios:
For a better understanding of MNMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.92 and its Current Ratio is at 5.92. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on July 24, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On May 29, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $27.
On April 15, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $20.Leerink Partners initiated its Outperform rating on April 15, 2024, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 25 ’24 when Karlin Dan sold 6,925 shares for $7.22 per share. The transaction valued at 49,998 led to the insider holds 351,527 shares of the business.
Sullivan Mark sold 17,854 shares of MNMD for $128,906 on Jun 25 ’24. The Chief Legal Officer now owns 182,146 shares after completing the transaction at $7.22 per share. On Jun 25 ’24, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 15,659 shares for $7.22 each. As a result, the insider received 113,058 and left with 564,543 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 517897952 and an Enterprise Value of 239961008.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -17.06%, while the 200-Day Moving Average is calculated to be -1.31%.
Shares Statistics:
Over the past 3-months, MNMD traded about 1.35M shares per day on average, while over the past 10 days, MNMD traded about 1057420 shares per day. A total of 41.10M shares are outstanding, with a floating share count of 27.18M. Insiders hold about 3.47% of the company’s shares, while institutions hold 144.01% stake in the company. Shares short for MNMD as of 1722384000 were 9977666 with a Short Ratio of 7.37, compared to 1719532800 on 7383486. Therefore, it implies a Short% of Shares Outstanding of 9977666 and a Short% of Float of 13.900000000000002.
